Insider trades
Dennis Mulroy, CFO of Arcturus Therapeutics Holdings ARCT, has filed 0 purchases and 13 sales on the open market. Over the past 12 months that comes to a net sale of $1.5M. The latest trade was on 05/01.
Dennis Mulroy
CFO
- First filing
- 23/01/10
- Trades
- 47 trades
- Buys / sales
- 0 / 13
- 12-month net buying
- −$1.5M
- Last trade
- 05/01
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
AnaptysbioANAB | Open-market sale | 01/08 | 01/09 | 2,515 sh | $44.71 | $112,445.65 | −10.3% |
AnaptysbioANAB | Open-market sale | 01/07 | 01/08 | 1,908 sh | $45.11 | $86,069.88 | −9.7% |
AnaptysbioANAB | Open-market sale | 01/05 | 01/06 | 3,363 sh | $43.26 | $145,483.38 | −19.0% |
AnaptysbioANAB | Open-market sale10b5-1 plan | 25/12/22 | 25/12/23 | 10,000 sh | $50.00 | $500,000 | −51.5% |
ANAB | Open-market sale10b5-1 plan | 25/12/16 | 25/12/18 | 15,725 sh2 trades | $44.86avg. | $705,401.9 | −62.6% |
ANAB | Open-market sale10b5-1 plan | 24/09/16 | 24/09/17 | 12,220 sh2 trades | $39.91avg. | $487,724.6 | −72.0% |
AnaptysbioANAB | Open-market sale10b5-1 plan | 24/05/22 | 24/05/24 | 1,500 sh | $23.72 | $35,580 | −60.9% |
AnaptysbioANAB | Open-market sale | 24/01/30 | 24/02/01 | 3,065 sh | $23.63 | $72,425.95 | −76.1% |
AnaptysbioANAB | Open-market sale | 24/01/08 | 24/01/09 | 2,180 sh | $21.81 | $47,545.8 | −35.1% |
ANAB | Open-market sale | 23/09/14–23/09/18 | 23/09/18 | 6,000 sh2 trades | $19.38avg. | $116,256.8 | −86.2% |
